Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
November 21, 2022 18:16 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investor Alert: Kaplan Fox Investigates Potential Securities Fraud
October 28, 2022 14:41 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) Investor Alert: Kaplan Fox Investigates Potential Securities Fraud
September 23, 2022 16:21 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...